By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.

The Voice of People With Breast Cancer


Educational Events

When to Consider Multi-Gene Testing in Early-Stage and Metastatic Breast Cancer

You can’t change your genes, but knowing and acting on your family health history is essential for you and your medical team in developing your treatment plan. The National Comprehensive Cancer Network (NCCN) recommends genetic testing, including the BRCA1/2 genes, for all metastatic breast cancer patients because it could change treatment decisions. Additionally, individuals with early-stage breast cancer may meet testing criteria based on their type of breast cancer or family history.

Guest speaker is Christina (Chrissy) Spears, Assistant Professor at Ohio State University; she also helps run the High-Risk Breast Cancer Clinic as a genetic counselor.




Key Topic(s):

Thursday, March 30th, at 6:00PM EST


  • Breast cancer patients
  • Their caregivers, families, and partners
  • BRCA1/2 tests
  • Other high-risk gene mutations called expanded panel testing or multi-gene testing 

To register click here.



Your path to accessing financial resources

Quick Find

Our Stories


See our calendar